Completed NA INTERVENTIONAL 2-arm NCT02418533

Mono-menotropins Versus rFSH Protocol on Embryo Quality

A Prospective, Randomized Trial to Compare Mono-menotropins Protocol for Controlled Ovarian Stimulation (COS) Versus Recombinant Follicle Stimulating Hormone (rFSH) Protocol on Embryo Quality Parameters in IVF Patients

Sponsor: Main Line Fertility Center

Conditions Fertility Infertility

Interventions Recominant Follicle Stimulating Hormone (rFSH) menotropin

Updated 7 times since 2017 Last updated: Aug 10, 2020 Started: Mar 31, 2015 Primary completion: Apr 30, 2017 Completion: Jul 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02418533, this NA trial focuses on Fertility and Infertility and remains completed. Sponsored by Main Line Fertility Center, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
Jul 2018 — Sep 2020 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Jul 2018 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Main Line Fertility Center

Data source: Main Line Fertility Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bryn Mawr, United States